Dynavax Technologies | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
AbbVie USD 1.66B 3.15B 2025-03
Adma Biologics USD 34.71M 2.04M 2024-12
Amgen USD 1.57B 405M 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Dynavax Technologies USD 21.22M 119.09M 2025-06
Gilead Sciences USD 2.43B 780M 2025-06
Glaxosmithkline USD 1.66B 1.78B 2024-12
Merck USD 6.77B 864M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Pfizer USD 3.04B 259M 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sarepta Therapeutics USD 153.64M 537.16M 2025-06
TG Therapeutics USD 30.92M 25.45M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06


Dynavax Technologies Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.